Zebra

Attention Zevra Therapeutics, Inc. Investors: Company Investigated by the Portnoy Law Firm

Retrieved on: 
Tuesday, April 9, 2024
Zebra, Bank statement, Annual report, Therapy, Audit committee, Cryptocurrency

​LOS ANGELES, April 08, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Zevra Therapeutics, Inc. (“Zevra” or the “Company”) (NASDAQ: ZVRA) investors that the law firm has initiated an investigation on behalf of investors that lost money on their Zevra stock. Zevra investors are encouraged to contact the firm to discuss their legal rights.

Key Points: 
  • ​LOS ANGELES, April 08, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Zevra Therapeutics, Inc. (“Zevra” or the “Company”) (NASDAQ: ZVRA) investors that the law firm has initiated an investigation on behalf of investors that lost money on their Zevra stock.
  • Zevra investors are encouraged to contact the firm to discuss their legal rights.
  • The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors’ options for pursuing claims to recover their losses.
  • On March 29, 2024, Zevra submitted a Current Report on Form 8-K to the United States Securities and Exchange Commission.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zevra Therapeutics, Inc. - ZVRA

Retrieved on: 
Monday, April 8, 2024
Zebra, News, LLP, Bank statement, Therapy, Pomerantz, Interim, Audit committee, Audit

NEW YORK, April 08, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Zevra Therapeutics, Inc. (“Zevra” or the “Company”) (NASDAQ: ZVRA).

Key Points: 
  • NEW YORK, April 08, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Zevra Therapeutics, Inc. (“Zevra” or the “Company”) (NASDAQ: ZVRA).
  • The investigation concerns whether Zevra and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.
  • The Firm has recovered billions of dollars in damages awards on behalf of class members.

Investigation Into Zevra Therapeutics, Inc. (ZVRA) Announced by Holzer & Holzer, LLC

Retrieved on: 
Tuesday, April 2, 2024
Zebra, Bank statement, Fraud, News, Therapy, ISS

ATLANTA, April 02, 2024 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether Zevra Therapeutics, Inc. (“Zevra” or the “Company”) (NASDAQ: ZVRA) complied with federal securities laws.

Key Points: 
  • ATLANTA, April 02, 2024 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether Zevra Therapeutics, Inc. (“Zevra” or the “Company”) (NASDAQ: ZVRA) complied with federal securities laws.
  • If you purchased Zevra stock and suffered a loss on that investment, you are encouraged to contact Corey Holzer, Esq.
  • Since its founding in 2000, Holzer & Holzer attorneys have played critical roles in recovering hundreds of millions of dollars for shareholders victimized by fraud and other corporate misconduct.
  • Holzer & Holzer, LLC has paid for the dissemination of this promotional communication, and Corey Holzer is the attorney responsible for its content.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zevra Therapeutics, Inc. - ZVRA

Retrieved on: 
Monday, April 1, 2024
Zebra, News, LLP, Bank statement, Therapy, Pomerantz, Interim, Audit committee, Audit

NEW YORK, April 01, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Zevra Therapeutics, Inc. (“Zevra” or the “Company”) (NASDAQ: ZVRA).

Key Points: 
  • NEW YORK, April 01, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Zevra Therapeutics, Inc. (“Zevra” or the “Company”) (NASDAQ: ZVRA).
  • The investigation concerns whether Zevra and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.
  • The Firm has recovered billions of dollars in damages awards on behalf of class members.

Zevra Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference

Retrieved on: 
Monday, March 25, 2024
Zebra, Conference, Disease, Therapy

CELEBRATION, Fla., March 25, 2024 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra or the Company), a rare disease therapeutics company, today announced that it will participate in the upcoming 23rd Annual Needham Virtual Healthcare Conference being held virtually on April 8-9, 2024.

Key Points: 
  • CELEBRATION, Fla., March 25, 2024 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra or the Company), a rare disease therapeutics company, today announced that it will participate in the upcoming 23rd Annual Needham Virtual Healthcare Conference being held virtually on April 8-9, 2024.
  • The Company’s presentation will take place on Monday, April 8, 2024, at 3:45 p.m.
  • Additionally, members of Zevra’s management team will be available for one-on-one investor meetings with registered attendees throughout the conference.
  • Following Zevra’s presentation, the archived presentation will be accessible under “Events & Presentations” on the Investor Relations section of Zevra’s website at investors.zevra.com.

Zevra Therapeutics to Report 2023 Fourth Quarter and Full Year Financial Results on March 28, 2024

Retrieved on: 
Monday, March 18, 2024
Zebra, Webcast, Therapy, Disease

CELEBRATION, Fla., March 18, 2024 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company) a rare disease therapeutics company, today announced that it will host a conference call and live audio webcast on Thursday, March 28, 2024, at 4:30 p.m.

Key Points: 
  • CELEBRATION, Fla., March 18, 2024 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company) a rare disease therapeutics company, today announced that it will host a conference call and live audio webcast on Thursday, March 28, 2024, at 4:30 p.m.
  • ET, to review its corporate and financial results for the fourth quarter and full year 2023.
  • The link to the audio webcast will be accessible via the Investor Relations section of the Company’s website, https://investors.zevra.com/ .
  • An archive of the webcast will be available for 90 days beginning at approximately 5:30 p.m.

ZEBRA PEN ANNOUNCES NATIONAL SONGWRITING SWEEPSTAKES CELEBRATING THE PATH TO SELF-EXPRESSION

Retrieved on: 
Wednesday, March 27, 2024
Marketing, Human, Social media, Zebra, Creativity, Zebra (pen manufacturer), Music

Zebra Pen is inviting songwriters to participate in the giveaway by sharing their written words on social media through videos.

Key Points: 
  • Zebra Pen is inviting songwriters to participate in the giveaway by sharing their written words on social media through videos.
  • This sweepstakes underscores Zebra Pen's commitment to the songwriting community, aiming to inspire the exploration of creative paths.
  • "At Zebra, we're passionate about fostering a network of creativity and self-expression," said Ken Newman, Director of Marketing at Zebra Pen Corporation.
  • Sweepstakes opens April 9 and closes May 9, 2024
    For more information on Zebra Pen Corporation visit, www.zebrapen.com

Zevra Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

Retrieved on: 
Tuesday, February 6, 2024
Therapy, Disease, Conference, Zebra

CELEBRATION, Fla., Feb. 06, 2024 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra or the Company), a rare disease therapeutics company, today announced that it will present at the upcoming Oppenheimer 34th Annual Healthcare Life Sciences Conference being held virtually on Tuesday, February 13, 2024, at 9:20 a.m.

Key Points: 
  • CELEBRATION, Fla., Feb. 06, 2024 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra or the Company), a rare disease therapeutics company, today announced that it will present at the upcoming Oppenheimer 34th Annual Healthcare Life Sciences Conference being held virtually on Tuesday, February 13, 2024, at 9:20 a.m.
  • Additionally, members of Zevra’s management team will be available for one-on-one investor meetings with registered attendees during the conference from February 13-14, 2024.
  • Following Zevra’s presentation, the archived presentation will be accessible under “Events & Presentations” on the Investor Relations section of Zevra’s website at investors.zevra.com .
  • To register for the conference, contact your Oppenheimer sales representative.

Dexory to Re-define North American Logistics and Warehousing Technology Market

Retrieved on: 
Monday, February 5, 2024
Technology, Transport, Professional Services, Software, Data Analytics, Electronic Design Automation, Robotics, Logistics, Supply Chain Management, Artificial Intelligence, Multimedia, Visibility, Aviation, Growth, Psion Teklogix, Motorola Solutions, Fetch, Manifest, Automation, Entrepreneurship, Zebra, ID, John Menzies, Acquisition, DB Schenker, Zebra Technologies, AMR, Organization

Dexory , a leading provider of cutting-edge AI and robotics solutions, has announced its strategic expansion into the North American market.

Key Points: 
  • Dexory , a leading provider of cutting-edge AI and robotics solutions, has announced its strategic expansion into the North American market.
  • To lead the expansion, Todd Boone has joined the team as its Head of North American business.
  • As part of the expansion, Dexory has appointed Todd Boone to lead its North American business.
  • “The opportunity to lead Dexory’s expansion into the North American market comes at an exciting time for the industry.

A Super Bowl LVIII Preview with Next Gen Stats

Retrieved on: 
Thursday, February 1, 2024
Technology, Sports, Other Technology, Football, Software, Electronic Design Automation, Robotics, Data Management, Artificial Intelligence, Bowl game, Marketing, Acceleration, Machine learning, AFL, Super Bowl, Verizon Communications, Mandalay Bay Convention Center, Artificial intelligence, Business development, Gen, Zebra, Lead, NGS, Zebra Technologies, AWS, NFL, Conference

Experts from the NFL, AWS and Zebra will also share data and insights for a Super Bowl preview powered by Next Gen Stats to help the media and fans know what to look for during the game.

Key Points: 
  • Experts from the NFL, AWS and Zebra will also share data and insights for a Super Bowl preview powered by Next Gen Stats to help the media and fans know what to look for during the game.
  • The panelists will discuss the application of artificial intelligence and machine learning to real-time player and ball tracking in the development of the latest Next Gen Stats which will enhance the Super Bowl fan experience in-stadium and via broadcast.
  • Amy Sullivan, North America & Sports Marketing Lead, Zebra Technologies
    Josh Helmrich, Senior Director, Media Strategy, Business Development & Next Gen Stats, NFL
    Mandalay Bay Convention Center, Super Bowl LVIII Media Center powered by Verizon, Press Conference B.
  • Note: A Super Bowl Week of Game credential or Day Pass is required for entry.